Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antiarrhythmics Drugs >  Propranolol hydrochloride

Propranolol hydrochloride

Basic information Safety Supplier Related

Propranolol hydrochloride Basic information

Product Name:
Propranolol hydrochloride
Synonyms:
  • (RS)-1-[(1-METHYLETHYL)AMINO]-3-(1-NAPHTHALENYLOXY)-2-PROPANOL HYDROCHLORIDE
  • PROPRANOLOL HCL
  • (+/-)-PROPRANOLOL HYDROCHLORIDE
  • PROPRANOLOL HYDROCHLORIDE
  • (+/-)-PROPANOLOL HCL
  • PROPANOLOL HYDROCHLORIDE
  • DL-Propranolol hydrochloride, 99% 5GR
  • Propranolol Hydrochloride (200 mg)
CAS:
318-98-9
MF:
C16H22ClNO2
MW:
295.8
EINECS:
206-268-7
Product Categories:
  • API's
  • Intermediates & Fine Chemicals
  • Aromatic alcohols and diols
  • Pharmaceuticals
  • Amines
  • INDERAL
  • APIs
  • Aromatics
  • Pharmaceutical intermediate
  • API
Mol File:
318-98-9.mol
More
Less

Propranolol hydrochloride Chemical Properties

Melting point:
163-165 °C(lit.)
Flash point:
9℃
storage temp. 
2-8°C
solubility 
H2O: 50 mg/mL, clear, colorless
form 
powder
color 
white
Water Solubility 
SOLUBLE
Merck 
14,7840
BRN 
4164259
BCS Class
1
InChIKey
ZMRUPTIKESYGQW-UHFFFAOYSA-N
CAS DataBase Reference
318-98-9(CAS DataBase Reference)
EPA Substance Registry System
Propranolol hydrochloride (318-98-9)
More
Less

Safety Information

Hazard Codes 
Xn,Xi,T,F
Risk Statements 
22-39/23/24/25-23/24/25-11
Safety Statements 
22-45-36/37-16-7
RIDADR 
UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany 
3
RTECS 
UB7525000
10
HazardClass 
IRRITANT
HS Code 
29221990
Hazardous Substances Data
318-98-9(Hazardous Substances Data)
Toxicity
LD50 in mice (mg/kg): 565 orally; 22 i.v.; 107 i.p. (Martin, Linee)

MSDS

More
Less

Propranolol hydrochloride Usage And Synthesis

Chemical Properties

Off-White to Light-Yellow Cyrstalline Solid

Uses

β?Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic (class II).

Uses

For the prophylaxis of migraine

Uses

Propranolol, a β-adrenergic blocker, is most commonly used to reduce blood pressure; treatment of over-active thyroid and some types of tremor; prevention of migraine headaches and some heart-rhythm problems; used to decrease the number of angina attacks (pain from an inadequate oxygen supply to the heart); used after a heart attack to prevent further damage to the heart.

Uses

(±)-Propranolol hydrochloride has been used:

  • to determine whether autonomic nervous system mediated the promotive effect on skin microcirculation in rat
  • as a non-selective β- receptor blocker to reduce the arrhythmogenic events
  • to study its effect on oxygen-induced retinopathy in mice

brand name

Inderal (Wyeth); Innopran (Reliant).

General Description

Propranolol hydrochloride is easily soluble in ethanol and water.

Biochem/physiol Actions

Propranolol hydrochloride is a β-adrenoceptor antagonist. Its action at β2 receptor results in bronchoconstriction. Due to its lipophilic nature, propranolol can penetrate to the central nervous system and has a negative effect. It serves as a 5-HT1/5-HT2 serotonin receptor antagonist. Propranolol hydrochloride is useful as an antihypertensive drug, cardiac depressant and also in the treatment of angina pectoris. It decreases the effect of stress and exercise on heart by reducing the rate of contraction and conduction of impulse. It is known to competitively block the action of catecholamines.

Clinical Use

Beta-adrenoceptor blocker:
Hypertension
Phaeochromocytoma
Angina
Arrhythmias
Anxiety
Migraine prophylaxis

Veterinary Drugs and Treatments

While propranolol is used for hypertension, migraine headache prophylaxis, and angina in human patients, it is used primarily in veterinary medicine for its antiarrhythmic effects. Dysrhythmias treated with propranolol include: atrial premature complexes, ventricular premature complexes, supraventricular premature complexes and tachyarrhythmias, ventricular or atrial tachyarrhythmias secondary to digitalis, atrial tachycardia secondary to Wolff-Parkinson-White (WPW) with normal QRS complexes, and atrial fibrillation (generally in combination with digoxin). Propranolol reportedly improves cardiac performance in animals with hypertrophic cardiomyopathy. It has been used to treat systemic hypertension and clinical signs associated with thyrotoxicosis and pheochromocytoma.

Drug interactions

Potentially hazardous interactions with other drugs
Anaesthetics: enhanced hypotensive effect; risk of bupivacaine toxicity increased.
Analgesics: NSAIDs antagonise hypotensive effect.
Anti-arrhythmics: increased risk of myocardial depression and bradycardia; increased risk of bradycardia, myocardial depression and AV block with amiodarone; concentration increased by propafenone and possibly dronedarone; increased risk of myocardial depression and bradycardia with flecainide; increased risk of lidocaine toxicity.
Antibacterials: metabolism increased by rifampicin.
Antidepressants: enhanced hypotensive effect with MAOIs; concentration increased by fluvoxamine; concentration of imipramine increased.
Antihypertensives; enhanced hypotensive effect; increased risk of withdrawal hypertension with clonidine; increased risk of first dose hypotensive effect with post-synaptic alpha-blockers such as prazosin.
Antimalarials: increased risk of bradycardia with mefloquine.
Antipsychotics enhanced hypotensive effect with phenothiazines; concentration of both drugs increased with chlorpromazine.
Calcium-channel blockers: increased risk of bradycardia and AV block with diltiazem; hypotension and heart failure possible with nifedipine and nisoldipine; asystole, severe hypotension and heart failure with verapamil.
Cytotoxics: possible increased risk of bradycardia with crizotinib.
Diuretics: enhanced hypotensive effect.
Fingolimod: possibly increased risk of bradycardia.
Moxisylyte: possible severe postural hypotension.
Sympathomimetics: severe hypertension with adrenaline and noradrenaline and possibly with dobutamine.

Metabolism

Propranolol is subject to considerable hepatic-tissue binding and first-pass metabolism. It is metabolised in the liver to an active metabolite (4-hydroxypropranolol) and several inactive ones.
The metabolites and small amounts of unchanged drug are excreted in the urine.

storage

Store at RT

Propranolol hydrochloride Preparation Products And Raw materials

Raw materials

Propranolol hydrochlorideSupplier

Zhongxiang Yaowei Biological Technology Co., Ltd. Gold
Tel
15337241005 13260682861
Email
w13260682861@qq.com
Shandong Kanghong International Trade Co. LTD Gold
Tel
0531-87229773 13156406177
Email
bianjianfenghg@163.com
Jiangxi ravel Biotechnology Co.,Ltd Gold
Tel
400-880-2824 18107960669
Email
79046690@qq.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com